Share

The Accelerating Science Podcast by SelectScience®
CRISPR, AI and how to be successful in pharma: Steve Rees, AstraZeneca
•
Join SelectScience® CEO, Kerry Parker, as she speaks to Steve Rees OBE, Vice President of Discovery Biology at AstraZeneca. Discover invaluable lessons we can all learn from Rees’ remarkable response to the Covid pandemic, which earned him a prestigious OBE. Explore the realities of working in the pharmaceutical industry, the incredible potential of CRISPR technology in therapeutics, and why AI is poised to revolutionize the scientific industry. Don't miss the opportunity to gain valuable insights from an industry leader who has harnessed the power of both innovation and communication to create a lasting impact.
More episodes
View all episodes

The spit queen: How Anne Wyllie is challenging the status quo in clinical testing
55:17|Join SelectScience® CEO, Kerry Parker, as she speaks to Dr. Anne Wyllie, also known as ‘The Spit Queen’, about her work in the use of saliva for high-quality, low-cost community surveillance of respiratory pathogens. Wyllie is a research scientist in the Department of Epidemiology of Microbial Diseases at the Yale School of Public Health at Yale University. During this conversation, we explore the story behind the development of the SalivaDirect PCR protocol which propelled Wyllie’s global mission of affordable, high-quality testing programs for all communities in need. Discover how the American National Basketball Association helped with this mission and why we should be challenging the status quo in clinical testing.
iKnife, AI and robotics: How Zoltan Takats is driving innovation in cancer care and research
01:00:05|Join SelectScience® CEO, Kerry Parker, as she speaks to Professor Zoltan Takats, Professor of Analytical Chemistry at the Faculty of Medicine, Imperial College London. In this episode, learn about the future possibilities of intelligent surgery, where AI and robotics assist surgeons with precision surgery and real-time decision-making, leading to improved outcomes for patients. Hear about the development of the iKnife and the challenges for academics in commercialising tools for the clinical lab. Discover the opportunities of moving from therapeutics to theranostics, which technologies will accelerate clinical research and how the future is a team affair. Join the conversation to hear about Takats’ personal mission to change how cancer care is performed.
Gene therapy, AI and mass spec: Mimi Roy discusses rare disease research in Silicon Valley
59:59|Join SelectScience® CEO, Kerry Parker, as she speaks to Dr. Mimi Roy who is working at the cutting edge of developing gene therapies in rare diseases. During this podcast discussion, Roy shares how gene therapies and viral vectors work and why AI and mass spectrometry are accelerating science in this field. Roy also discusses her perspectives on time management, her outlook on teamwork, and how the future of science is a multidisciplinary and human endeavour. After beginning her academic career in India, Roy embarked on a journey that led her to Sydney, Australia, and eventually the United States, where she pursued her Ph.D. in Chemistry at Princeton University then a postdoctoral research position at the Scripps Research Institute. Roy then discovered the world of start-ups and biopharmaceuticals and never looked back.
The path to invention: How Alexander Makarov continues to revolutionize mass spectrometry and Orbitrap
54:08|Join SelectScience® CEO, Kerry Parker, as she speaks to Professor Alexander Makarov, a renowned Russian physicist and engineer. Makarov is best known for his leading role in the development of the Orbitrap mass spectrometry technology, used today by tens of thousands of scientists worldwide in proteomics, drug discovery, cell biology, forensics, and more. As the Director of Global Research in Life Sciences Mass Spectrometry at Thermo Fisher Scientific, Makarov and his team are continuing to drive new innovations in the field. In this podcast episode, we dive into Makarov’s life story and discover his path to invention. Makarov shares the unique challenges of being a scientist in a technology company, explains how mass spectrometry works and the concept of democratization in scientific advancements. Don't miss this thought-provoking episode, where we uncover the remarkable journey of Professor Alexander Makarov and the impact of his innovations.